Two Sigma Securities’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,373
| Closed | -$569K | – | 1882 |
|
|
2025
Q4 | $569K | Buy |
+3,373
| New | +$548K | 0.08% | 340 |
|
|
2025
Q3 | – | Sell |
-4,647
| Closed | -$588K | – | 1674 |
|
|
2025
Q2 | $588K | Buy |
+4,647
| New | +$570K | 0.07% | 367 |
|
|
2024
Q3 | – | Sell |
-7,023
| Closed | -$964K | – | 3200 |
|
|
2024
Q2 | $964K | Buy |
7,023
+1,681
| +31% | +$224K | 0.01% | 1088 |
|
|
2024
Q1 | $733K | Sell |
5,342
-2,558
| -32% | -$349K | 0.01% | 1312 |
|
|
2023
Q4 | $1.07M | Buy |
7,900
+1,558
| +25% | +$190K | 0.01% | 1004 |
|
|
2023
Q3 | $776K | Buy |
+6,342
| New | +$807K | 0.01% | 1218 |
|
|
2023
Q1 | – | Sell |
-4,048
| Closed | -$531K | – | 2929 |
|
|
2022
Q4 | $531K | Sell |
4,048
-8,877
| -69% | -$1.15M | 0.02% | 1045 |
|
|
2022
Q3 | $1.51M | Buy |
+12,925
| New | +$1.61M | 0.05% | 457 |
|
|
2022
Q2 | – | Sell |
-4,546
| Closed | -$592K | – | 2504 |
|
|
2022
Q1 | $592K | Buy |
4,546
+710
| +19% | +$92.5K | 0.02% | 891 |
|
|
2021
Q4 | $585K | Buy |
+3,836
| New | +$594K | 0.03% | 456 |
|
|
2021
Q2 | – | Sell |
-22,514
| Closed | -$3.47M | – | 1581 |
|
|
2021
Q1 | $3.39M | Buy |
+22,514
| New | +$3.58M | 0.19% | 55 |
|
|
2020
Q4 | – | Sell |
-7,937
| Closed | -$1.13M | – | 1791 |
|
|
2020
Q3 | $1.07M | Buy |
+7,937
| New | +$1.08M | 0.02% | 337 |
|
|
2020
Q2 | – | Sell |
-12,685
| Closed | -$1.62M | – | 1525 |
|
|
2020
Q1 | $1.37M | Buy |
+12,685
| New | +$1.46M | 0.03% | 321 |
|
|
2019
Q4 | – | Sell |
-8,124
| Closed | -$906K | – | 2481 |
|
|
2019
Q3 | $808K | Sell |
8,124
-19,101
| -70% | -$2M | 0.01% | 977 |
|
|
2019
Q2 | $2.97M | Buy |
27,225
+20,399
| +299% | +$2.17M | 0.03% | 351 |
|
|
2019
Q1 | $763K | Sell |
6,826
-68,792
| -91% | -$7.55M | 0.01% | 671 |
|
|
2018
Q4 | $7.29M | Buy |
75,618
+65,900
| +678% | +$6.99M | 0.09% | 117 |
|
|
2018
Q3 | $1.19M | Buy |
+9,718
| New | +$1.14M | 0.01% | 956 |
|
|
2018
Q2 | – | Sell |
-4,597
| Closed | -$492K | – | 2793 |
|
|
2018
Q1 | $491K | Sell |
4,597
-27,080
| -85% | -$3M | ﹤0.01% | 1673 |
|
|
2017
Q4 | $3.38M | Buy |
31,677
+6,834
| +28% | +$730K | 0.09% | 167 |
|
|
2017
Q3 | $2.76M | Sell |
24,843
-29,022
| -54% | -$3.1M | 0.25% | 94 |
|
|
2017
Q2 | $5.57M | Sell |
53,865
-72,930
| -58% | -$7.18M | 1.06% | 15 |
|
|
2017
Q1 | $12.4M | Buy |
+126,795
| New | +$12.1M | 2.43% | 3 |
|
|
2016
Q3 | – | Sell |
-3,348
| Closed | -$287K | – | 720 |
|
|
2016
Q2 | $287K | Sell |
3,348
-29,478
| -90% | -$2.64M | 0.16% | 178 |
|
|
2016
Q1 | $2.85M | Buy |
32,826
+29,202
| +806% | +$2.61M | 3.67% | 4 |
|
|
2015
Q4 | $409K | Buy |
3,624
+75
| +2% | +$8.14K | 0.49% | 36 |
|
|
2015
Q3 | $359K | Buy |
+3,549
| New | +$426K | 0.56% | 52 |
|
|
2015
Q2 | – | Sell |
-1,821
| Closed | -$208K | – | 211 |
|
|
2015
Q1 | $208K | Buy |
+1,821
| New | +$201K | 0.21% | 117 |
|
Other funds holding IBB
CB
Two Sigma Securities's IBB Position: Q1 2026 in Review
Two Sigma Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 3,373 shares — an estimated $569K sold.
Two Sigma Securities first reported a position in IBB in Q1 2015 and held it in 28 quarters. The position peaked at $12.4M in Q1 2017. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Two Sigma Securities reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 3,373 iShares Biotechnology ETF shares in Q1 2026, an estimated $569K.
- Two Sigma Securities first reported a position in iShares Biotechnology ETF in Q1 2015 and held it in 28 quarters.
- Two Sigma Securities's iShares Biotechnology ETF position peaked at $12.4M in Q1 2017.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.